Cargando…
National guideline concordance and outcomes for pathologic N2 disease in non-small cell lung cancer
BACKGROUND: Real-world treatment practices for positive mediastinal nodal disease in non-small cell lung cancer (NSCLC) continues to vary despite guidelines. We aim to assess national trends in the treatment of pathologic-N2 disease, and evaluate the association with clinical nodal staging and timin...
Autores principales: | Mitzman, Brian, Varghese, Thomas K., Kuchta, Kristine, Krantz, Seth B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9186219/ https://www.ncbi.nlm.nih.gov/pubmed/35693597 http://dx.doi.org/10.21037/jtd-21-1845 |
Ejemplares similares
-
Germline mutations in high penetrance genes are associated with worse clinical outcomes in patients with non–small cell lung cancer
por: Krantz, Seth B., et al.
Publicado: (2022) -
Adhering to guideline concordant care improves survival among the different subtypes of T3 N2 non–small cell lung cancer
por: Wang, Jennifer C., et al.
Publicado: (2022) -
Differential outcomes of residual disease in surgically-resected non-small cell lung cancer and the importance of guideline-concordant adjuvant therapy
por: Lieu, Dustin K., et al.
Publicado: (2021) -
Breast Cancer Care in South India: Is Practice Concordant With National Guidelines?
por: Vijaykumar, D.K., et al.
Publicado: (2019) -
Twenty-one-year follow-up revealed guideline-concordant and non-concordant trends in intensive care of bronchiolitis
por: Selin, Sofia, et al.
Publicado: (2023)